David Berry (inventor)

From Wikipedia, the free encyclopedia
David Berry
Speaker pic 20151011.png
David Berry on October 11, 2015
Born (1978-02-10) February 10, 1978 (age 43)
New York City, New York
EducationMIT, Harvard Medical School
OccupationCEO, innovator, venture capitalist, entrepreneur, inventor,

David Berry (born February 10, 1978) is an American entrepreneur and business executive. He has co-founded numerous companies in life sciences, technology, and sustainability, including Seres Therapeutics, Indigo Agriculture, and Axcella Health.

Early life and education[]

Berry was born in 1978. He graduated Hackley School in Tarrytown, NY in 1996. Berry graduated with a S.B. Phi Beta Kappa and Sigma Xi from the Massachusetts Institute of Technology in 2000. He earned his M.D. from Harvard Medical School and his PhD from the Massachusetts Institute of Technology with Robert Langer and Ram Sasisekharan.[citation needed]

Valo Health[]

Berry founded Valo Health in 2019.[1][2]

Flagship Pioneering[]

Berry joined Flagship Pioneering in 2005, a Cambridge, Massachusetts based venture capital firm that creates and funds early-stage start-ups addressing unmet needs in healthcare and sustainability where he served as a general partner.[3]

Seres Therapeutics[]

Seres Therapeutics
Nasdaq: MRCB
Russell 2000 Index component

In 2012, Berry founded Seres Therapeutics, which pioneered microbiome therapeutics.[4] The company raised over $130M as a private company, including a $65M investment from Nestle Health Sciences.[5] Seres publicly listed on the Nasdaq under the symbol MCRB in June 2015, raising $134M.[6] Seres signed a partnership valued at $2B with Nestle Health Sciences in early 2016.[7]

Indigo Agriculture[]

In 2014, Berry founded Indigo to create seed treatments that optimize the health of a plant to increase yield.[8]

Axcella Health[]

Axcella Health
Nasdaq: AXLA
Russell 2000 Index component

In 2009, Berry founded Axcella Health, which is pioneering defined a new approach to treating complex diseases and supporting health using Endogenous Metabolic Modulators (EMMs) as a new therapeutic product class.[9]

Evelo Biosciences[]

Evelo Biosciences
Nasdaq: EVLO
Russell 2000 Index component

In 2014, Berry founded Evelo Biosciences.[10]

Joule Unlimited[]

In 2007, Berry founded Joule Unlimited. In March 2010 [11] and again in March 2011, Joule was named by Technology Review as one of the 50 Most Innovative Companies. Joule was named as one of the 10 most important emerging technologies in 2011.[12]

Other affiliations[]

Berry is a founding member of the Leadership Council of the United Nations Sustainable Development Solutions Network, which authored the Sustainable Development Goals.[13] The Sustainable Development Goals contains 17 goals and 169 targets agreed to by 193 countries at the United Nations[14] to foster sustainable development with a 2030 target.[15]

Berry is a trustee at the Hackley School,[16] and was previously a member of the corporation of the Massachusetts Institute of Technology, its board, from 2006-2011.[17] David has also served as a board member of the Juventas New Music Ensemble.[18] and of the Boston Philharmonic Orchestra.

Honors[]

Berry was selected as a 2014 Young Global Leader by the World Economic Forum.[19] He was named as the Innovator of the Year in 2007 by the MIT Technology Review TR35 list of one of the top 35 innovators in the world under the age of 35 for his creation of LS9.[20] Additionally Berry has been recognized by the US State Department as one of 12 Innovators Helping Reshape Reality.[21]

References[]

  1. ^ "This is Intelligent Health". Valo. Retrieved 2020-10-06.
  2. ^ Knapp, Alex. "This Startup Has Raised Nearly $100 Million To Make Good On The Promise Of AI For Drug Discovery". Forbes. Retrieved 2020-10-06.
  3. ^ "David Berry". Flagship Pioneering. Retrieved 2020-10-06.
  4. ^ "Establishing a Better Microbiome for Better Health". Seres Therapeutics. Retrieved 2020-10-01.
  5. ^ Merced, Michael J. de la. "Nestlé Health Science to Invest $65 Million in a Biotech Start-Up".
  6. ^ "Seres guts out a $134M IPO to fuel microbiome R&D". FierceBiotech.
  7. ^ "Seres Inks Nestlé As Potential $2B Partner; Key Microbiome Data Soon - Xconomy". 11 January 2016.
  8. ^ "Flagship VentureLabs™ Introduces Symbiota, Pioneer of Agricultural Innovation Through the Plant Microbiome - Symbiota". 13 November 2014. Archived from the original on 20 November 2015. Retrieved 25 October 2015.
  9. ^ "PIONEERING A NEW PATH TO HEALTH".
  10. ^ "HOME".
  11. ^ "MIT Technology Review's 50 Smartest Companies 2015, from Tesla to Uber - MIT Technology Review". MIT Technology Review.
  12. ^ "10 Breakthrough Technologies 2015 - MIT Technology Review". MIT Technology Review.
  13. ^ "Sustainable Development Solutions Network - Leadership Council". unsdsn.org. Archived from the original on 2017-09-03. Retrieved 2014-03-19.
  14. ^ "World leaders adopt Sustainable Development Goals".
  15. ^ "Press release – UN General Assembly's Open Working Group proposes sustainable development goals" (PDF). Sustainabledevelopment.un.org. 19 July 2014. Retrieved 2016-10-18.
  16. ^ "Trustees & Administration". hackleyschool.org.
  17. ^ "Members of the MIT Corporation". mit.edu.
  18. ^ "About - Juventas New Music Ensemble". juventasmusic.com.
  19. ^ "Meet the 2014 class of Young Global Leaders". Agenda - The World Economic Forum. Archived from the original on 2014-10-21. Retrieved 2014-03-18.
  20. ^ "2007 TR35: Innovator of the Year". MIT Technology Review. Retrieved 2020-10-06.
  21. ^ Innovators Help Reshape Reality, January 2, 2008
Retrieved from ""